NON-PHARMACOLOGICAL METHODS IN STROKE MANAGEMENT IN PATIENTS WITH ATRIAL FIBRILLATION: FROM INTERVENTIONAL METHODS TO SURGERY ; НЕФАРМАКОЛОГИЧЕСКИЕ МЕТОДЫ В ПРОФИЛАКТИКЕ ИНСУЛЬТОВ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ: ОТ ИНТЕРВЕНЦИОННЫХ ПОДХОДОВ К ХИРУРГИИ

Συγγραφείς: Elizaveta D. Strebkova, Elena A. Artyukhina, Madina Kadirova, Amiran S. Revishvili, Елизавета Дмитриевна Стребкова, Елена Александровна Артюхина, Мадина Кадырова, Амиран Шотаевич Ревишвили

Συνεισφορές: Авторы заявляют об отсутствии финансирования статьи.

Πηγή: Complex Issues of Cardiovascular Diseases; Том 14, № 4 (2025); 102-122 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 14, № 4 (2025); 102-122 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Окклюдер, Left atrial appendage, Isolation, Occluder, Ушко левого предсердия, Изоляция, Ампутация

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1697/1079; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1697/2103; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1697/2104; Krijthe, B.P. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 / B.P. Krijthe, A. Kunst, E.J. Benjamin, G.Y. H. Lip, O.H. Franco, A. Hofman, J.C.M. Witteman, B.H. Stricker, J. Heeringa // Eur Heart J. – 2013. – Vol. 34. - №35. – P. 2746-2751. https://doi.org/10.1093/eurheartj/eht280; Edgerton J.R., Brinkman W.T., Weaver T., Prince S.L., Culica D., Herbert M.A. et al. Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach. J Thorac Cardiovasc Surg. 2010;140:823–8; Babapoor-Farrokhran S, Alzubi J, Port Z, Kaul R, Rasekhi RT, Farrokhran AB, Sooknanan N, Wiener PC, Khraisha O, Frishman WH, Mainigi SK, Aronow WS. Left Atrial Appendage Closure: What Do We Know? Cardiol Rev. 2025 Mar-Apr 01;33(2):153-159. https://doi.org/10.1097/crd.0000000000000601; Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, Løchen ML, Lumbers RT, Maesen B, Mølgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3314-3414. https://doi.org/10.1093/eurheartj/ehae176; Колбин, А. С. Социально-экономическое бремя фибрилляции предсердий в России: динамика за 7 лет (2010–2017 годы) / А. С. Колбин, А. А. Мосикян, Б. А. Татарский // Вестник аритмологии. – 2018.–№ 92. – С. 42–48; Филатов А.Г., Тарашвили Э.Г. / Эпидемиология и социальная значимость фибрилляции предсердий. // Анналы аритмологии. - 2012. - № 2. - С.5-13; Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., LloydJones D., Goff D.C. Jr., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S, Wilson M, Wolf P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85-151. PMID: 16407573. http://dx.doi.org/10.1161/ CIRCULATIONAHA.105.171600; Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-8. PMID: 1866765; Martín Gutiérrez E, Castaño M, Gualis J, Martínez-Comendador JM, Maiorano P, Castillo L, Laguna G. Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients. Eur J Cardiothorac Surg. 2020 Feb 1;57(2):252-262. https://doi.org/10.1093/ejcts/ezz289; Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001;285:2370–5; Fang MC, Go AS, Chang Y, et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2008; 51: 810-5; Deitelzweig S, Bergrath E, di Fusco M, Kang A, Savone M, Cappelleri JC, Russ C, Betts M, Cichewicz A, Schaible K, Tarpey J, Fahrbach K. Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol. 2022 May;18(5):393-405. doi:10.2217/fca-2021-0120; Сердечная Е.В., Татарский Б. А., Казакевич Е.В. Особенности распространенности и течения фибрилляции предсердий на северо-западе Российской Федерации. Клиническая медицина. 2009;87(1):17-20; Goette A., Kalman J.M., Aguinaga L., et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Europace. 2016; 18: 1455-1490; Burdett, P. & Lip, G. Y. H. Atrial fibrillation in the United Kingdom: predicting costs of an emerging epidemic recognising and forecasting the cost drivers of atrial fibrillation-related costs. Eur. Heart J. Qual. Care Clin. Outcomes https://doi.org/10.1093/ehjqcco/qcaa093; Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation. Nat Rev Dis Primers. 2022 Apr 7;8(1):21. https://doi.org/10.1038/s41572-022-00347-9; Deitelzweig S, Bergrath E, di Fusco M, Kang A, Savone M, Cappelleri JC, Russ C, Betts M, Cichewicz A, Schaible K, Tarpey J, Fahrbach K. Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol. 2022 May;18(5):393-405. https://doi.org/10.2217/fca-2021-0120; Мамчур СЕ, Иваницкий ЭА, Поликутина ОМ, Чичкова ТЮ, Мамчур ИН, Романова МП, Хоменко ЕА. Эффективность выявления мерцательной аритмии при криптогенном инсульте по данным имплантируемых мониторов электрокардиограммы: пилотное исследование. Сибирский журнал клинической и экспериментальной медицины. 2019;34(2):47-53. https://doi.org/10.29001/2073-8552-2019-34-2-47-53; Nouh A, Hussain M, Mehta T, Yaghi S. Embolic strokes of unknown source and cryptogenic stroke: implications in clinical practice. Front Neurol 2016;7:37; Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O'Donnell MJ et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13:429–38; Abstract 38: Hemorrhagic Strokes in Patients with Atrial Fibrillation: The Neuro-AFib Study. Stroke. 2021;52; Holmes DR Jr, Korsholm K, Rodés-Cabau J, Saw J, Berti S, Alkhouli MA. Left atrial appendage occlusion. EuroIntervention. 2023 Feb 6;18(13):e1038-e1065. https://doi.org/10.4244/eij-d-22-00627; Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, и соавт. Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156. doi:10.1161/CIR.0000000000001193. Epub 2023 Nov 30. Erratum in: Circulation. 2024 Jan 2;149(1):e167. doi:10.1161/CIR.0000000000001207. Erratum in: Circulation. 2024 Feb 27;149(9):e936. https://doi.org/10.1161/cir.0000000000001193; Holmes, D.; Kar, S.; Price, M.; Whisenant, B.; Sievert, H.; Doshi, S.; Huber, K.; Reddy, V. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long term warfarin therapy. J. Am. Coll. Cardiol. 2014, 8, 1–12; Piccini JP, Sievert H, Patel MR. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. Eur Heart J 2017;38:869–76. https://doi.org/10.1093/eurheartj/ehw330; Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010; 122: 109–118; Madden JL. Resection of the left auricular appendix: a prophylaxis for recurrent arterial emboli. Journal of the American Medical Association. 1949; 140: 769; Agnino A, Giroletti L, Graniero A, Gerometta P, Parrinello M, Albano G, Celentano E, Cristiano E, Nasso G, de Groot NMS. Robotic-Assisted Epicardial Hybrid Ablation and Left Appendage Closure in Persistent Atrial Fibrillation: First European Experience. J Clin Med. 2024 Mar 8;13(6):1563.; Branzoli S, Guarracini F, Marini M, D'Onghia G, Catanzariti D, Merola E, Annicchiarico L, Casagranda G, Stegagno C, Fantinel M, La Meir M. Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective. J Clin Med. 2022 Nov 1;11(21):6492 https://doi.org/10.3390/jcm11216492; R. Cartledge, G. Suwalski, A. Witkowska, et al. Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation Interact Cardiovasc Thorac Surg, 34 (2022), pp. 548-555; Rose DZ, DiGiorgi P, Ramlawi B, Pulungan Z, Teigland C, Calkins H. Minimally invasive epicardial surgical left atrial appendage exclusion for atrial fibrillation patients at high risk for stroke and for bleeding. Heart Rhythm. 2024 Jun;21(6):771-779. https://doi.org/10.1016/j.hrthm.2024.01.046; Marini M, Pannone L, Branzoli S, Tedoldi F, D'Onghia G, Fanti D, Sarao E, Guarracini F, Quintarelli S, Monaco C, Graffigna A, Bonmassari R, La Meir M, Chierchia GB, de Asmundis C. Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy. Front Cardiovasc Med. 2022 Nov 7;9:1036574. https://doi.org/10.3389/fcvm.2022.1036574; Rozen G, Margolis G, Marai I, Roguin A, Rahamim E, Planer D, Heist EK, Amir O, Tahiroglu I, Ruskin J, Mansour M, Elbaz-Greener G. Left atrial appendage exclusion in atrial fibrillation. Front Cardiovasc Med. 2022 Sep 13;9:949732. https://doi.org/10.3389/fcvm.2022.949732; PROTECT-AF Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534–42. https://doi.org/10.1016/S0140-6736(09)61343-X; PREVAIL Waksman R, Pendyala LK. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy. Am J Cardiol 2015;115:378–84. https://doi.org/10.1016/j.amjcard.2014.11.011; мета-анализ Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 2017;70:2964–75. https://doi.org/10.1016/j.jacc.2017.10.021; PRAGUE-17 Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol 2020;75:3122–35. https://doi.org/10.1016/j.jacc.2020.04.067; Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage closure versus non-warfarin oral anticoagulation in atrial fibrillation: 4-year outcomes of PRAGUE-17. J Am Coll Cardiol 2022;79:1–14. https://doi.org/10.1016/j.jacc.2021.10.023; Kim KS, Mandrola J, McIntyre WF, Whitlock RP, Belley-Cote EP. Primary composite outcome in PRAGUE-17: an unintended butterfly effect. J Am Coll Cardiol 2022;79:e497. https://doi.org/10.1016/j.jacc.2022.01.056; Turagam MK, Osmancik P, Neuzil P, Dukkipati SR, Reddy VY. Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials. J Am Coll Cardiol 2020;76:2795–7. https://doi.org/10.1016/j.jacc.2020.08.089; Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion—an update. EuroIntervention 2020;15:1133–80. https://doi.org/10.4244/EIJY19M08_01; D. Lakkireddy, D. Thaler, C.R. Ellis, et al. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial Circulation, 144 (2021), pp. 1543-1552; Park, J.W. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience / J.W. Park, A. Bethencourt, H. Sievert, G. Santoro, B. Meier, K. Walsh, J.R. Lopez-Minguez, D. Meerkin, M. Valdés, O. Ormerod, B. Leithäuser // Catheter Cardiovasc Interv. – 2011. – Vol. 77. - № 5. – P. 700-6. https://doi.org/10.1002/ccd.22764; Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981–92. https://doi.org/10.1056/NEJMoa1107039; Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806–17. https://doi.org/10.1056/NEJMoa1007432; Turagam, M.; Osmancik, P.; Neuzil, P.; Dukkipati, S.; Reddy, V. Left atrial appendage closure versus oral anticoagulants in atrial fibrillation, A meta-analysis of randomized trials. J. Am. Coll. Cardiol. 2020, 76, 2795–2797; Boersma, L.; Ince, H.; Kische, S.; Pokushalov, E.; Scmitz, T.; Schmidt, B.; Gori, T.; Meincke, F.; Protopopov, A.; Betts, T.; et al. Evaluating real world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology. Circ. Arrhythm. Electrophysiol. 2019, 12, e006841; Hildick-Smith, D.; Landmesser, U.; Camm, J.; Diener, H.; Paul, V.; Scmidt, B.; Settergren, M.; Teiger, N.; Nielsen-Kudsk, J.; Tondo, C. Left atrial appendage occlusion with the Amplatezer Amulet device: Full results of the prospective global observational study. Eur. Heart J. 2020, 41, 2894–2901; Li, X.; Wen, S.N.; Li, S.N.; Bai, R.; Liu, N.; Feng, L.; Ruan, Y.; Du, X.; Dong, J.; Ma, C. Over 1 year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies. Heart Rhythm 2016, 13, 1203–1214; Holmes DR, Lakkireddy DR, Whitlock RP, Waksman R, Mack MJ. Left atrial appendage occlusion: opportunities and challenges. J Am Coll Cardiol. 2014;63:291-298; Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108-118; M.A. Miller, S.R. Gangireddy, S.K. Doshi, A. Aryana, J.S. Koruth, S. Sennhauser, et al. A Multi-Center Study on Acute and Long-Term Safety and Efficacy of Percutaneous Left Atrial Appendage Closure using an Epicardial Suture Snaring Device Heart Rhythm, 11 (2014), pp. 1853-1859; M.J. Price, D.N. Gibson, S.J. Yakubov, J.C. Schultz, L. Di Biase, A. Natale, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium J Am Coll Cardiol, 64 (2014), pp. 565-572; Dar T, Afzal MR, Yarlagadda B, Kutty S, Shang Q, Gunda S, Samanta A, Thummaluru J, Arukala KS, Kanmanthareddy A, Reddy M, Atkins D, Bommana S, Dawn B, Lakkireddy D. Mechanical function of the left atrium is improved with epicardial ligation of the left atrial appendage: Insights from the LAFIT-LARIAT Registry. Heart Rhythm. 2018;15:955-959; L. Di Biase, J.D. Burkhardt, D.N. Gibson, A. Natale 2D and 3D TEE evaluation of an early reopening of the LARIAT epicardial left atrial appendage closure device Heart Rhythm, 11 (2014), pp. 1087-1088; W.J. Mosley 2nd, M.R. Smith, M.J. Price Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke Catheter Cardiovasc Interv, 83 (2014), pp. 664-669; M.S. Baker, J. Paul Mounsey, A.K. Gehi, E.H. Chung Left atrial thrombus after appendage ligation with LARIAT Heart Rhythm, 85 (2015), pp. E54-E57; Litwinowicz, R.; Bartus, M.; Burysz, M.; Brzezinky, M.; Swalsky, P.; Kapelak, B.; Vuddanda, V.; Lakkireddy, D.; Lee, R.; Trabka, R.; et al. Long term outcomes after left atrial appendage closure with LARIAT device-Stroke risk reduction over five years follow up. PLoS ONE 2018, 13, e0208710; Parikh, V.; Bartus, K.; Litwinowicz, R.; Turagam, M.; Sadowsky, J.; Kapelak, B.; Bartus, M.; Podolec, J.; Brzezinsky, M.; Musat, D.; et al. Long Term clinical outcomes from real world experience of left atrial appendage exclusion with LARIAT device. J. Cardiovasc. Electrophysiol. 2019, 30, 2849–2857; Tilz, R.; Fink, T.; Bartus, K.; Wong, T.; Volger, J.; Netwich, K.; Panniker, S.; Fang, Q.; Piorkowsky, C.; Liosis, S.; et al. A collective European experience with left atrial appendage suture ligation using the lariat device. Europace 2020, 22, 924–931; Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, et al. Association of surgical left atrial appendage occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery. JAMA 2018;319:2116–26. https://doi.org/10.1001/jama.2018.6024; Landmesser U, Skurk C, Tzikas A, Falk V, Reddy VY, Windecker S. Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives. Eur Heart J. 2024 Aug 21;45(32):2914-2932. https://doi.org/10.1093/eurheartj/ehae398; Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc 2016;5:e003074. https://doi.org/10.1161/JAHA.115.003074; Squiers, J.J. Surgical Closure of the Left Atrial Appendage: The Past, The Present, The Future / J.J. Squiers, J.R. Edgerton // J Atr Fibrillation. – 2018. – Vol. 10. - № 5. – P. 1642. https://doi.org/10.4022/jafib.1642; Johnson, W.D. The left atrial appendage: our most lethal human attachment! Surgical implications / W.D. Johnson, A.K. Ganjoo, C.D. Stone, R.C. Srivyas, M. Howard // Eur J Cardiothorac Surg. – 2000. – Vol. 17. - № 6. – P. 718-22. https://doi.org/10.1016/s1010-7940(00)00419-x; Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008;52:924–9. https://doi.org/10.1016/j.jacc.2008.03.067; Katz, E.S. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiographic study / E.S. Katz, T. Tsiamtsiouris, R.M. Applebaum, A. Schwartzbard, P.A. Tunick, I. Kronzon // J Am Coll Cardiol. – 2000. – Vol. 36. - № 2. – P. 468-471. https://doi.org/10.1016/s0735-1097(00)00765-8; Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150:288–293. doi:10.1016/j.ahj.2004.09.054; Lee Richard, JivanArif, KruseJane, McGeeEdwin C, MalaisrieS Chris, BernsteinRichard, LapinBrittany, PassmanRod, KnightBradley P, McCarthyPatrick M. Late neurologic events after surgery for atrial fibrillation: rare but relevant. Ann. Thorac. Surg. 2013;95 (1):126–31; Friedman DJ, Piccini JP, Wang T, Zheng J, Malaisrie SC, Holmes DR, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery. JAMA 2018;319:365–74. https://doi.org/10.1001/jama.2017.20125; Gerdisch MW, Garrett HE Jr, Mumtaz MA, Grehan JF, Castillo-Sang M, Miller JS, et al. Prophylactic left atrial appendage exclusion in cardiac surgery patients with elevated CHA(2)DS(2)-VASc score: results of the randomized ATLAS trial. Innovations (Phila) 2022;17:463–70. https://doi.org/10.1177/15569845221123796; LAAOS III Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med 2021;384:2081–91. https://doi.org/10.1056/NEJMoa2101897; Martín Gutiérrez E. Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients / E. Martín Gutiérrez, M. Castaño, J. Gualis, J.M. Martínez-Comendador, P. Maiorano, L. Castillo, G. Laguna // Eur J Cardiothorac Surg. – 2020. – Vol. 57. - № 2. – P. 252-262. https://doi.org/10.1093/ejcts/ezz289; Atti V, Anantha-Narayanan M, Turagam MK, Koerber S, Rao S, Viles-Gonzalez JF et al. Surgical left atrial appendage occlusion during cardiac surgery: a systematic review and meta-analysis. World J Cardiol 2018;10:242–9; Emmert MY, Firstenberg MS, Martella AT, Lau L, Zlock S, Mohan A, Spangler T, Currie S, Salzberg SP, Caliskan E. Epicardial left atrial appendage occlusion with a new medical device: assessment of procedural feasibility, safety and efficacy in a large animal model. J Cardiothorac Surg. 2020 Apr 3;15(1):56. https://doi.org/10.1186/s13019-020-01096-0; Ventosa-Fernandez G, Quintana E, Castellá M, Pereda D. Exclusion of the left atrial appendage with the TigerPaw II system: a word of caution. Interact Cardiovasc Thorac Surg. 2015 Dec;21(6):803-4. https://doi.org/10.1093/icvts/ivv256; Suwalski G, Emery R, Gryszko L, Kaczejko K, Żegadło A, Frankowska E, Mróz J, Skrobowski A. Early operative comparison of two epicardial left atrial appendage occluding systems applied during off-pump coronary revascularisation in patients with persistent atrial fibrillation. Kardiochir Torakochirurgia Pol. 2016 Mar;13(1):10-4. https://doi.org/10.5114/kitp.2016.58958; Salzberg Sacha P, GillinovAlan Marc, AnyanwuAnelechi, CastilloJavier, FilsoufiFarzan, AdamsDavid H. Surgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imaging. Eur J Cardiothorac Surg. 2008;34 (4):766–70; Ailawadi Gorav, GerdischMarc W, HarveyRichard L, HookerRobert L, DamianoRalph J, SalamonThomas, MackMichael J. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J. Thorac. Cardiovasc. Surg. 2011;142 (5):1002–9, 1009.e1; Emmert Maximilian Y, PuippeGilbert, BaumüllerStephan, AlkadhiHatem, LandmesserUlf, PlassAndre, BettexDominique, SchermanJacques, GrünenfelderJürg, GenoniMichele, FalkVolkmar, SalzbergSacha P. Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg. 2014;45 (1):126–31; Ramlawi B, Bedeir K, Edgerton JR. Totally Thoracoscopic Closure of the Left Atrial Appendage. Ann Thorac Surg. 2019 Jan;107(1):e71-e73. https://doi.org/10.1016/j.athoracsur.2018.07.046; van Laar C, Verberkmoes NJ, van Es HW, Lewalter T, Dunnington G, Stark S, Longoria J, Hofman FH, Pierce CM, Kotecha D, van Putte BP. Thoracoscopic Left Atrial Appendage Clipping: A Multicenter Cohort Analysis. JACC Clin Electrophysiol. 2018 Jul;4(7):893-901. https://doi.org/10.1016/j.jacep.2018.03.009; Inui R, Yoshimoto T, Ishiyama H, Kurashima S, Nakagawa S, Kitai T, Izumi C, Ihara M. Cardioembolism after thoracoscopic left atrial appendage clipping in a patient on oral anticoagulation therapy. J Cardiol Cases. 2023 Sep 9;29(1):5-6. https://doi.org/10.1016/j.jccase.2023.08.016; Bedeir, K. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation / K. Bedeir, D.R. Holmes, J.L. Cox, B. Ramlawi // J Thorac Cardiovasc Surg. – 2017. – Vol. 153. - № 5. – P. 1097-1105. https://doi.org/10.1016/j.jtcvs.2016.12.040; Deitelzweig, S. Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis / S. Deitelzweig, E. Bergrath, M. di Fusco, A. Kang, M. Savone, J. C. Cappelleri, C. Russ, M. Betts, A. Cichewicz, K. Schaible, J. Tarpey, K. Fahrbach // Future Cardiol. – 2022. – Vol. 18. - №5. – P. 393-405. https://doi.org/10.2217/fca-2021-0120; Ellis, C.R. Angiographic efficacy of the Atriclip left atrial appendage exclusion device placed by minimally invasive thoracoscopic approach / C.R. Ellis, S.G. Aznaurov, N.J. Patel, J.R. Williams, K.L. Sandler, S.J. Hoff, S.K. Ball, S.P. Whalen, J.J. Carr // JACC Clin Electrophysiol. – 2017. – Vol. 3. - № 12. – P. 1356-65. https://doi.org/10.1016/j.jacep.2017.03.008; Blackshear, J.L. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation / J.L. Blackshear, W.D. Johnson, J.A. Odell, et al. // J Am Coll Cardiol. – 2003. – Vol. 42. - № 7. – P. 1249-1252. https://doi.org/10.1016/s0735-1097(03)00953-7; Ailawadi, G. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial / G. Ailawadi, M.W. Gerdisch, R.L. Harvey, R.L. Hooker, R.J. Jr Damiano, T. Salamon, M.J. Mack // J Thorac Cardiovasc Surg. – 2011. – Vol. 142. - № 5. – P. 1002-9. https://doi.org/10.1016/j.jtcvs.2011.07.052; Salzberg, S.P. Left atrial appendage clip occlusion: early clinical results / S.P. Salzberg, A. Plass, M.Y. Emmert, L. Desbiolles, H. Alkadhi, J. Grünenfelder, M. Genoni // J Thorac Cardiovasc Surg. – 2010. – Vol. 139. - № 5. – P. 1269-74. https://doi.org/10.1016/j.jtcvs.2009.06.033; Osmancik, P. Residual echocardiographic and computed tomography findings after thoracoscopic occlusion of the left atrial appendage using the AtriClip PRO device / P. Osmancik, P. Budera, J. Zdarska, D. Herman, R. Petr, R. Fojt, Z. Straka // Interact Cardiovasc Thorac Surg. – 2018. – Vol. 26. - № 6. – P. 919-925. https://doi.org/10.1093/icvts/ivx427; Ревишвили А.Ш., Кадырова М., Стребкова Е.Д., Малышенко Е.С., Новиков М.А., Ялова Е.В., Бабаджанова К.А., Бондурко К.Э., Кармазановский Г.Г. Ампутация ушка левого предсердия с использованием эндостеплера при торакоскопической аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2023;12(1):58-71. https://doi.org/10.17802/2306-1278-2023-12-1-58-71 / Revishvili A.Sh., Kadirova M., Strebkova E.D., Malishenko E.S., Novikov M.A., Yalova E.V., Babadjanova K.A., Bandurko K.E., Karmazanovsky G.G. Left atrial appendage exclusion using a stapler with thoracoscopic ablation of atrial fibrillation. Complex Issues of Cardiovascular Diseases. 2023;12(1):58-71. (In Russ.) https://doi.org/10.17802/2306-1278-2023-12-1-58-71; C. Toale, G.J. Fitzmaurice, D. Eaton, J. Lyne, K.C. Redmond Outcomes of left atrial appendage occlusion using the AtriClip device: a systematic review Interact Cardiovasc Thorac Surg, 29 (2019), pp. 655-662; Suwalski P, Witkowska A, Drobiński D, Rozbicka J, Sypuła S, Liszka I et al. Stand-alone totally thoracoscopic left atrial appendage exclusion using a novel clipping system in patients with high risk of stroke—initial experience and literature review. Kardiochir Torakochirurgia Pol 2015;12:298–303; Smith NE, Joseph J, Morgan J, Masroor S. Initial experience with minimally invasive surgical exclusion of the left atrial appendage with an epicardial clip. Innovations (Phila) 2017;12:28–32; Caliskan, E.; Eberhard, M.; Alkadhi, V.F.H.; Emmert, M. Incidence and characteristics of left atrial appendage stumps after device-enabled epicardial closure. Interact. Cardiovasc. Thorac. Surg. 2019, 29, 663–669; Lempereur, M.; Aminian, A.; Freixa, X.; Gafoor, S.; Kefer, J.; Tzikas, A.; Legrand, V.; Saw, J. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac plug and the Amulet. Catheter. Cardiovasc. Interv. 2018, 92, e216–e217; Cartledge, R.; Suwalski, G.; Witkowska, A.; Gottlieb, G.; Cioci, A.; Chidiac, G.; Ilsin, B.; Merrill, B.; Suwalsky, P. Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation. Interact. Cardiovasc. Thor. Surg. 2021, 34, 548–555; Ohtsuka, T.; Nonaka, T.; Hisagi, M.; Ninomiya, N.; Masukawa, A.; Ota, T. Thoracoscopic stapler-and-loop technique for left atrial appendage closure in nonvalvular atrial fibrillation: Mid-term outcomes in 201 patients. Heart Rhythm. 2018, 15, 1314–1320

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1697
https://doi.org/10.17802/2306-1278-2025-14-4-102-122

INFLUENCE OF PREVIOUS CATHETER ABLATIONS ON THE EFFICACY OF THORACOSCOPIC TREATMENT OF ATRIAL FIBRILLATION ; ВЛИЯНИЕ ПРЕДШЕСТВУЮЩИХ КАТЕТЕРНЫХ АБЛАЦИЙ НА ЭФФЕКТИВНОСТЬ ТОРАКОСКОПИЧЕСКОГО ЛЕЧЕНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ

Συγγραφείς: Elizaveta D. Strebkova, Elena A. Artyukhina, Madina Kadirova, Amiran S. Revishvili, Елизавета Дмитриевна Стребкова, Елена Александровна Артюхина, Мадина Кадырова, Амиран Шотаевич Ревишвили

Συνεισφορές: Авторы заявляют об отсутствии финансирования статьи.

Πηγή: Complex Issues of Cardiovascular Diseases; Том 13, № 3S (2024): приложение; 87-97 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 13, № 3S (2024): приложение; 87-97 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Катетерная аблация, Thoracoscopic Ablation, Catheter Ablation, Торакоскопическая аблация

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1519/934; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1519/1738; Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю., Голицын С.П., Голухова Е.З., Горев М.В., Давтян К.В., Драпкина О.М., Кропачева Е.С., Кучинская Е.А., Лайович Л.Ю., Миронов Н.Ю., Мишина И.Е., Панченко Е.П., Ревишвили А.Ш., Рзаев Ф.Г., Татарский Б.А., Уцумуева М.Д., Шахматова О.О., Шлевков Н.Б., Шпектор А.В., Андреев Д.А., Артюхина Е.А., Барбараш О.Л., Галявич А.С., Дупляков Д.В., Зенин С.А., Лебедев Д.С., Михайлов Е.Н., Новикова Н.А., Попов С.В., Филатов А.Г., Шляхто Е.В., Шубик Ю.В. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):4594. doi:10.15829/1560-4071-2021-4594; Krijthe B.P., Kunst A., Benjamin E.J., Lip G.Y., Franco O.H., Hofman A., Witteman J.C., Stricker B.H., Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-51. doi:10.1093/eurheartj/eht280.; Колбин А.С., Мосикян А.А., Татарский Б.А. Социально-экономическое бремя фибрилляции предсердий в россии: динамика за 7 лет (2010-2017 годы). Вестник аритмологии. 2018;(92):42-48.; Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., Fauchier L., Filippatos G., Kalman J.M., La Meir M., Lane D.A., Lebeau J.P., Lettino M., Lip G.Y.H., Pinto F.J., Thomas G.N., Valgimigli M., Van Gelder I.C., Van Putte B.P., Watkins C.L.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi:10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021;42(5):507. doi:10.1093/eurheartj/ehaa798.; Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-221. doi:10.1177/1747493019897870.; Сердечная Е.В., Татарский Б.А., Казакевич Е.В. Особенности распространенности и течения фибрилляции предсердий на северо-западе Российской Федерации. Клиническая медицина. 2009; 87 (1):17-20.; Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., de Ferranti S., Després J.P., et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322. doi:10.1161/CIR.0000000000000152. Epub 2014 Dec 17. Erratum in: Circulation. 2015 Jun 16;131(24):e535. doi:10.1161/CIR.0000000000000219.; Brundel B.J.J.M., Ai X., Hills M.T., Kuipers M.F., Lip G.Y.H., de Groot N.M.S. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):21. doi:10.1038/s41572-022-00347-9.; Deitelzweig S., Bergrath E., di Fusco M., Kang A., Savone M., Cappelleri J.C., Russ C., Betts M., Cichewicz A., Schaible K., Tarpey J., Fahrbach K. Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol. 2022;18(5):393-405. doi:10.2217/fca-2021-0120.; Филатов А.Г., Тарашвили Э. Г. Эпидемиология и социальная значимость фибрилляции предсердий. Анналы аритмологии. 2012; 9 (2):.5-13.; Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Métayer P., Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659-66. doi:10.1056/NEJM199809033391003.; Brooks A.G., Stiles M.K., Laborderie J., Lau D.H., Kuklik P., Shipp N.J., Hsu L.F., Sanders P. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm. 2010;7(6):835-846. doi:10.1016/j.hrthm.2010.01.017; Sultan A., Lüker J., Andresen D., Kuck K.H., Hoffmann E., Brachmann J., Hochadel M., Willems S., Eckardt L., Lewalter T., Senges J., Steven D. Predictors of atrial fibrillation recurrence after catheter ablation: data from the German Ablation Registry. Sci Rep. 2017;7(1):16678. doi:10.1038/s41598-017-16938-6; Ganesan A.N., Shipp N.J., Brooks A.G., Kuklik P., Lau D.H., Lim H.S., Sullivan T., Roberts-Thomson K.C., Sanders P. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549. doi:10.1161/JAHA.112.004549; Park J.-W., Yu H.T., Kim T.-H., Uhm J.-S., Kim J.-Y., Joung B., Lee M.H., Pak H.N. Trends and outcome of catheter ablation of atrial fibrillation over 9 years―focus on empirical extra-pulmonary vein ablation. Circ J 2019;83:304–12.; Choi S.H., Yu H.T., Kim D., Park J.W., Kim T.H., Uhm J.S., Joung B., Lee M.H., Hwang C., Pak H.N. Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome. Europace. 2023;25(5):euad113. doi:10.1093/europace/euad113; Marrouche N.F., Wazni O., McGann C., Greene T., Dean J.M., Dagher L., Kholmovski E., Mansour M., Marchlinski F., Wilber D., Hindricks G., Mahnkopf C., Wells D., Jais P., Sanders P., Brachmann J., Bax J.J., Morrison-de Boer L., Deneke T., Calkins H., Sohns C., Akoum N.; DECAAF II Investigators. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. JAMA. 2022;327(23):2296-2305; Lin W.S., Tai C.T., Hsieh M.H., Tsai C.F., Lin Y.K., Tsao H.M., Huang J.L., Yu W.C., Yang S.P., Ding Y.A., Chang M.S., Chen S.A. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation. 2003;107(25):3176-83. doi:10.1161/01.CIR.0000074206.52056.2D; Hindricks G., Potpara T., Dagres NArbelo E., Bax J.J., Blomström-Lundqvist C., Boriani G., Castella M., Dan G.A., Dilaveris P.E., Fauchier L., Filippatos G., Kalman J.M., La Meir M., Lane D.A., Lebeau J.P., Lettino M., Lip G.Y.H., Pinto F.J., Thomas G.N., Valgimigli M., Van Gelder I.C., Van Putte B.P., Watkins C.L.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi:10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021;42(5):507. doi:10.1093/eurheartj/ehaa798.; Wolf R.K., Schneeberger E.W., Osterday R., Miller D., Merrill W., Flege J.B.Jr., Gillinov A.M. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797-802. doi:10.1016/j.jtcvs.2005.03.041.; Yu C., Li H., Zhang H. Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation. Interact Cardiovasc Thorac Surg. 2021;33(3): 354-361. doi:10.1093/icvts/ivab148.; Boersma L.V., Castella M., van Boven W., Berruezo A., Yilmaz A., Nadal M., Sandoval E., Calvo N., Brugada J., Kelder J., Wijffels M., Mont L. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125: 23-30. doi:10.1161/CIRCULATIONAHA.111.074047.; Sindby J.E., Vadmann H., Lundbye-Christensen S., Riahi S., Hjortshøj S., Boersma L.V.A., Andreasen J.J. Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial–the FAST II study. J Cardiothorac Surg. 2018;13(1): 101. doi:10.1186/s13019-018-0792-8.; Driessen A.H., Berger W.R., Chan Pin Yin D.R., Piersma F.R., Neefs J., van den Berg N.W., Krul S.P., van Boven W.P., de Groot J.R. Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up. J Am Coll Cardiol. 2017;69(13):1753-1754. doi:10.1016/j.jacc.2017.01.035.; Wesselink R., Vroomen M., Overeinder I., Neefs J., van den Berg N.W.E., Meulendijks E.R., Piersma F.R., Al-Shama R.F.M., de Vries T.A.C., Verstraelen T.E., Luermans J., Maesen B., de Asmundis C., Chierchia G.B., La Meir M., Pison L., van Boven W.J.P., Driessen A.H.G., de Groot J.R. A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablation. Rev Esp Cardiol (Engl Ed). 2023; 76(6):417-426. doi:10.1016/j.rec.2022.09.006; Lim S.K., Kim J.Y., On Y.K., Jeong D.S. Mid-Term Results of Totally Thoracoscopic Ablation in Patients with Recurrent Atrial Fibrillation after Catheter Ablation. Korean J Thorac Cardiovasc Surg. 20205;53(5):270-276. doi:10.5090/kjtcs.19.059.; Стребкова Е.Д., Ревишвили А.Ш., Малышенко Е.С., Артюхина Е.А., Попов В.А., Новиков М.А., Ялова Е.В., Бондурко К.Э., Кармазановский Г.Г., Кадырова М. Отдаленные результаты торакоскопического лечения фибрилляции предсердий. Вестник аритмологии. 2023;30(2):59-69. doi:10.35336/VA-2023-2-08.; Ревишвили А.Ш., Стребкова Е.Д., Артюхина Е.А., Малышенко Е.С., Новиков М.А., Кадырова М. Эффективность торакоскопического лечения непароксизмальных форм фибрилляции предсердий. Вестник аритмологии. 2023;30(3):23-31. doi:10.35336/VA-1160; Ревишвили А.Ш., Кадырова М., Стребкова Е.Д., Малышенко Е.С., Новиков М.А., Ялова Е.В., Бабаджанова К.А., Бондурко К.Э., Кармазановский Г.Г. Ампутация ушка левого предсердия с использованием эндостеплера при торакоскопической аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2023;12(1):58-71. doi:10.17802/2306-1278-2023-12-1-58-71; Kim J., Jeon K., Park S.J., Jeong D.S., Chung S., Bak M., Kim D., Kim E.K., Chang S.A., Lee S.C., Park S.W. Prognostic implication of left atrial strain in patients experiencing early recurrence of atrial fibrillation after totally thoracoscopic ablation. Ann Cardiothorac Surg. 2024;13(1):77-87. doi:10.21037/acs-2023-afm-fs-0031; Yu C., Li H., Zhang H., Zheng Z. Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation. Interact Cardiovasc Thorac Surg. 2021;33(3):354-361. doi:10.1093/icvts/ivab148; Zheng Z., Li H., Liu S., Gao G., Yu C., Lin H., Meng Y. Box lesion or bi-atrial lesion set for atrial fibrillation during thoracoscopic epicardial ablation. Interact Cardiovasc Thorac Surg. 2022;34(1):1-8. doi:10.1093/icvts/ivab211; van Laar C., Bentala M., Weimar T., Doll N., Swaans M.J., Molhoek S.G., Hofman F.N., Kelder J., van Putte B.P. Thoracoscopic ablation for the treatment of atrial fibrillation: a systematic outcome analysis of a multicentre cohort. Europace. 2019;21(6):893-899. doi:10.1093/europace/euy323; On Y.K., Park K.M., Jeong D.S., Park P.W., Lee Y.T., Park S.J., Kim J.S. Electrophysiologic Results After Thoracoscopic Ablation for Chronic Atrial Fibrillation. Ann Thorac Surg. 2015 Nov;100(5):1595-602; discussion 1602-3. doi:10.1016/j.athoracsur.2015.04.127; Hwang J.K., Jeong D.S., Gwag H.B., Park K.M., Ahn J., Carriere K., Park S.J., Kim J.S., On Y.K. Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation. PLoS One. 2018;13(10):e0205431. doi:10.1371/journal.pone.0205431; de Asmundis C., Chierchia G.B., Mugnai G., Van Loo I., Nijs J., Czapla J., Conte G., Velagic V., Rodrigues Mañero M., Ciconte G., Ströker E., Umbrain V., Poelaert J., Brugada P., La Meir M. Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience. Europace. 2017;19(1):58-65. doi:10.1093/europace/euw026

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1519
https://doi.org/10.17802/2306-1278-2024-13-3S-87-97

STEREOTACTIC RADIOABLATION AS A NON-INVASIVE APPROACH IN THE TREATMENT OF PERSISTENT ATRIAL FIBRILLATION ; СТЕРЕОТАКСИЧЕСКАЯ РАДИОАБЛАЦИЯ КАК НЕИНВАЗИВНЫЙ МЕТОД ЛЕЧЕНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ

Συγγραφείς: Elizaveta D. Strebkova, Elena A. Artyukhina, Amiran S. Revishvili, Елизавета Дмитриевна Стребкова, Елена Александровна Артюхина, Амиран Шотаевич Ревишвили

Συνεισφορές: Авторы заявляют об отсутствии финансирования статьи.

Πηγή: Complex Issues of Cardiovascular Diseases; Том 13, № 2 (2024); 116-127 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 13, № 2 (2024); 116-127 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Онкология, Stereotactic radioablation, Older patients, Oncology, Стереотаксическая радиоаблация, Пожилые пациенты

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1465/894; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1465/1631; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1465/1632; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1465/1633; Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю., Голицын С.П., Голухова Е.З., Ревишвили А.Ш. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;(26):4594. doi:10.15829/1560-4071-2021-4594.; Шапкина М.Ю., Маздорова Е.В., Авдеева Е.М., Щербакова Л.В., Рябиков А.Н., Hubacek J., Bobak M., Малютина С.К. Динамика частоты фибрилляции предсердий в российской популяционной выборке за 13 лет наблюдения. Кардиоваскулярная терапия и профилактика. 2022;21(8):3108. doi:10.15829/1728-8800-2022-3108.; Стребкова Е.Д., Ревишвили А.Ш., Малышенко Е.С., Артюхина Е.А., Попов В.А., Новиков М.А., Ялова Е.В., Бондурко К.Э., Кармазановский Г.Г., Кадырова М. Отдаленные результаты торакоскопического лечения фибрилляции предсердий. Вестник аритмологии. 2023;30(2):59-69. doi:10.35336/VA-2023-2-08.; Krijthe B.P., Kunst A., Benjamin E.J., Lip G.Y. H., Franco O.H., Hofman A., Witteman J.C.M., Stricker B.H., Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-2751. doi:10.1093/eurheartj/eht280.; Сердечная Е.В., Татарский Б.А., Казакевич Е.В. Особенности распространенности и течения фибрилляции предсердий на северо-западе Российской Федерации. Клиническая медицина. 2009;87(1):17-20.; Jakobsen C.B., Lamberts M., Carlson N., Lock-Hansen M., Torp-Pedersen C., Gislason G.H. Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study. BMC Cancer. 2019;(19):1105. doi:10.1186/s12885-019-6314-9.; Ревишвили А.Ш., Стребкова Е.Д., Артюхина Е.А., Малышенко Е.С., Новиков М.А., Кадырова М. Эффективность торакоскопического лечения непароксизмальных форм фибрилляции предсердий. Вестник аритмологии. 2023;30(3):23-31. https://doi.org/10.35336/VA-1160.; Brundel B.J.J.M., Ai X., Hills M.T., Kuipers M.F., Lip G.Y.H., de Groot N.M.S. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):21. doi:10.1038/s41572-022-00347-9.; Филатов А.Г., Тарашвили Э.Г. Эпидемиология и социальная значимость фибрилляции предсердий. Анналы аритмологии. 2012;(2):5-13.; Haïssaguerre M., Jaȉs P., Shah D.C. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666. doi:10.1056/NEJM199809033391003.; Cuculich P.S., Schill M.R., Kashani R., Mutic S., Lang A., Cooper D. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377:2325–36. doi:10.1056/NEJMoa1613773; Cox J.L. The longstanding, persistent confusion surrounding surgery for atrial fibrillation. J Thorac Cardiovasc Surg. 2010;139:1374–86. doi:10.1016/j.jtcvs.2010.02.027.; Ganesan A.N., Shipp N.J., Brooks A.G. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004549. doi:10.1161/JAHA.112.004549.; Kennedy R., Oral H. Catheter ablation of atrial fibrillation in the elderly: does the benefit outweigh the risk? Expert Rev Cardiovasc Ther 2013;11:697–704. doi:10.1586/erc.13.2.; Prasitlumkum N., Tokavanich N., Trongtorsak A., Cheungpasitporn W., Kewcharoen J., Chokesuwattanaskul R. Catheter ablation for atrial fibrillation in the elderly >75 years old: systematic review and meta-analysis. J Cardiovasc Electrophysiol 2022;33:1435–49. doi:10.1111/jce.15549.; Whitaker J., Mak R.H., Zei P.C. Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy. Trends Cardiovasc Med. 2022;32(5):287-296. doi:10.1016/j.tcm.2021.04.008.; Refaat M.M., Zakka P., Youssef B., Zeidan Y.H., Geara F., Al-Ahmad A. Noninvasive Cardioablation. Card Electrophysiol Clin. 2019;11(3):481-485. doi:10.1016/j.ccep.2019.05.008.; Васковский В.А., Таймасова И.А., Калинин Д.В., Антипина Н.А., Николаева А.А., Смирнов Г.Ю., Голанов А.В., Потапов А.А., Ревишвили А.А. Применение стереотаксической радиохирургии в эксперименте на крупных животных для проведения неинвазивных вмешательств в аритмологии. Вестник аритмологии. 2021;28(1):5-13. doi:10.35336/VA-2021-1-5-13.; Таймасова И.А., Васковский В.А., Артюхина Е.А., Антипина Н.А., Николаева А.А., Смирнов Г.Ю., Сизов В.А., Букарев А.Е., Фадеева О.В., Голанов А.В., Потапов А.А., Ревишвили А.Ш. Возможности и перспективы применения стереотаксической радиохирургии для проведения неинвазивных вмешательств в аритмологии. Вестник аритмологии. 2020;27(4):33-41. doi:10.35336/VA-2020-4-33-41.; Loo B.W., Soltys S.G., Wang L., Lo A., Fahimian B.P., Iagaru A. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2015;8:748–50. doi:10.1161/CIRCEP.115.002765.; Robinson C.G., Samson P.P., Moore K.M.S., Hugo G.D., Knutson N., Mutic S., Goddu S.M., Lang A., Cooper D.H., Faddis M., Noheria A., Smith T.W., Woodard P.K., Gropler R.J., Hallahan D.E., Rudy Y., Cuculich P.S. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019;139:313–21. doi:10.1161/CIRCULATIONAHA.118.038261.; Gianni C., Rivera D., Burkhardt J.D., Pollard B., Gardner E., Maguire P., Zei P.C., Natale A., Al-Ahmad A. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm. 2020;17:1241–8. doi:10.1016/j.hrthm.2020.02.036; Sharma A., Wong D., Weidlich G., Fogarty T., Jack A., Sumanaweera T., Maguire P. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. 2010;7:802–10. doi:10.1016/j.hrthm.2010.02.010; Lehmann H.I., Richter D., Prokesch H., Graeff C., Prall M., Simoniello P., Fournier C., Bauer J., Kaderka R., Weymann A., Szabó G., Sonnenberg K., Constantinescu A.M., Johnson S.B., Misiri J., Takami M., Miller R.C., Herman M.G., Asirvatham S.J., Brons S., Jäkel O., Haberer T., Debus J., Durante M., Bert C., Packer D.L. Atrioventricular node ablation in langendorff-perfused porcine hearts using carbon ion particle therapy. Circ Arrhythm Electrophysiol. 2015;8:429–38. doi:10.1161/CIRCEP.114.002436.; Gardner E.A., Weidlich G.A. Analysis of Dose Distribution in the Heart for Radiosurgical Ablation of Atrial Fibrillation. Cureus. 2016;8(7):e703. doi:10.7759/cureus.703.; Bode F., Blanck O., Gebhard M., Hunold P., Grossherr M., Brandt S., Vonthein R., Thiele H., Dunst J., Rades D. Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation. 2015;17(12):1868-74. doi:10.1093/europace/euu406.; Zei P.C., Wong D., Gardner E., Fogarty T., Maguire P. Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model. Heart Rhythm. 2018;15(9):1420-1427. doi:10.1016/j.hrthm.2018.04.015.; Gardner E.A., Sumanaweera T.S., Blanck O., Iwamura A.K., Steel J.P., Dieterich S., Maguire P. In vivo dose measurement using tlds and MOSFET dosimeters for cardiac radiosurgery. J Appl Clin Med Phys. 2012;13:190–203. doi:10.1120/jacmp.v13i3.3745; Chang J.H., Cha M.J., Seo J.W., Kim H.J., Park S.Y., Kim B.H., Lee E., Kim M.K., Yoon H.S., Oh S. Feasibility study on stereotactic radiotherapy for total pulmonary vein isolation in a canine model. Sci Rep. 2021;11:12369. doi:10.1038/s41598-021-91660-y; Ren X.Y., He P.K., Gao X.S., Zhao Z.L., Zhao B., Bai Y., Liu S.W., Li K., Qin S.B., Ma M.W., Zhou J., Rong Y. Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity-modulated proton therapy. J Appl Clin Med Phys. 2021;22(5):79-88. doi:10.1002/acm2.13239; Xia P., Kotecha R., Sharma N. A treatment planning study of stereotactic body radiotherapy for atrial fibrillation. Cureus. 2016;8:e678. doi:10.7759/cureus.678.; Blanck O., Ipsen S., Chan M.K. Treatment planning considerations for robotic guided cardiac radiosurgery for atrial fibrillation. Cureus. 2016;8:e705. doi:10.7759/cureus.705.; Ipsen S., Blanck O., Oborn B. Radiotherapy beyond cancer: target localization in real-time MRI and treatment planning for cardiac radiosurgery. Med Phys. 2014;41:120702. doi:10.1118/1.4901414.; Sharma A., Wong D., Weidlich G., Fogarty T., Jack A., Sumanaweera T. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. 2010;7:802–10. doi:10.1016/j.hrthm.2010.02.010.; Shoji M., Inaba K., Itami J., Hamada M., Okamoto H., Iwasa T., Ushigusa T., Yoshida M., Matsuyama T.A., Otsuka T., Kumagai K., Hirao K., Maguire P., Qian P., Gardner E., Zei P.C. Advantages and challenges for noninvasive atrial fibrillation ablation. J Interv Card Electrophysiol. 2021;62:319–27. doi:10.1007/s10840-020-00904-w/Published.; Di Monaco A., Gregucci F., Bonaparte I., Romanazzi I., Troisi F., Surgo A., Vitulano N., Quadrini F., Valenti N., Carbonara R., Di Guglielmo F.C., Ludovico E., Calbi R., Guida P., Ciliberti M.P., Fiorentino A., Grimaldi M. Linear accelerator-based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly: a prospective phase II trial. Europace. 2023;25(12):euad344. doi:10.1093/europace/euad344.; Haskova J., Jedlickova K., Cvek J., Knybel L., Neuwirth R., Kautzner J. Oesophagopericardial fistula as a late complication of stereotactic radiotherapy for recurrent ventricular tachycardia. Europace. 2022:euab326. doi:10.1093/europace/euab326.; Monroy E., Azpiri J., De La Peña C., Cardona C., Hinojosa M., Zamarripa R., Assad J. Late gadolinium enhancement cardiac magnetic resonance imaging post robotic radiosurgical pulmonary vein isolation (RRPVI). First case in the world. Cureus. 2016;8:e738. doi:10.7759/cureus.738.; Qian P.C., Azpiri J.R., Assad J., Gonzales Aceves E.N., Cardona Ibarra C.E., de la Pena C., Hinojosa M., Wong D., Fogarty T., Maguire P., Jack A., Gardner E.A., Zei P.C. Noninvasive stereotactic radioablation for the treatment of atrial fibrillation: first-in-man experience. J Arrhythmia. 2020;36:67–74. doi:10.1002/joa3.12283.; Blanck O., Bode F., Gebhard M., Hunold P., Brandt S., Bruder R., Grossherr M., Vonthein R., Rades D., Dunst J. Dose-escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys. 2014;89:590–8. doi:10.1016/j.ijrobp.2014.02.036.; Maguire P.J., Gardner E., Jack A.B., Zei P., Al-Ahmad A., Fajardo L. Cardiac radiosurgery (CyberHeartTM) for treatment of arrhythmia: physiologic and histopathologic correlation in the porcine model. Cureus. 2011;3:e32. doi:10.7759/cureus.32.; Chalkia M., Kouloulias V., Tousoulis D., Deftereos S., Tsiachris D., Vrachatis D., Platoni K. Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations. Biomedicines. 2021;9(10):1461. doi:10.3390/biomedicines9101461.; Kovacs B., Mayinger M., Schindler M., Steffel J., Andratschke N., Saguner A.M. Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – a systematic review. Radiother Oncol. 2021;162:132–9. doi:10.1016/j.radonc.2021.06.036.; Martin A.G.R., Coltart D.J., Plowman P.N. CyberKnife radiosurgery for an intracardiac metastasis. BMJ Case Rep. 2011:bcr0720103197. doi:10.1136/bcr.07.2010.3197.; Soltys S.G., Kalani M.Y., Cheshier S.H., Szabo K.A., Lo A., Chang S.D. Stereotactic radiosurgery for a cardiac sarcoma: a case report. Technol Cancer Res Treat. 2008;7:363–8. doi:10.1177/153303460800700502.; Bonomo P., Cipressi S., Desideri I., Masi L., Doro R., Iermano C. Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. Tumori. 2015;101:294–7. doi:10.5301/tj.5000280.; Adams M.J., Lipshultz S.E., Schwartz C., Fajardo L.F., Coen V., Constine L.S. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol. 2003;13:346–56. doi:10.1016/S1053-4296(03)00026-2.; Gagliardi G., Constine L.S., Moiseenko V., Correa C., Pierce L.J., Allen A.M. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76:S77–85. doi:10.1016/j.ijrobp.2009.04.093.; Filippi A.R., Meregalli S., Di Russo A., Levis M., Ciammella P., Buglione M. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum. Radiat Oncol. 2020;15:62. doi:10.1186/s13014-020-01504-8.; Haasbeek C.J.A., Lagerwaard F.J., Slotman B.J., Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol. 2011;6:2036–43. doi:10.1097/JTO.0b013e31822e71d8.; Kaestner L., Boda-Heggemann J., Fanslau H., Xie J., Schweikard A., Giordano F.A., Blanck O., Rudic B. Electroanatomical mapping after cardiac radioablation for treatment of incessant electrical storm: a case report from the RAVENTA trial. Strahlenther Onkol. 2023;199(11):1018-1024. doi:10.1007/s00066-023-02136-z.; Krug D., Zaman A., Eidinger L., Grehn M., Boda-Heggemann J., Rudic B., Mehrhof F., Boldt L.H., Hohmann S., Merten R., Buergy D., Fleckenstein J., Kluge A., Rogge A., Both M., Rades D., Tilz R.R., Olbrich D., König I.R., Siebert F.A., Schweikard A., Vonthein R., Bonnemeier H., Dunst J., Blanck O. Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial. Strahlenther Onkol. 2023;199(7):621-630. doi:10.1007/s00066-023-02091-9.

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1465
https://doi.org/10.17802/2306-1278-2024-13-2-116-127

EVOLUTION OF THORACOSCOPIC TREATMENT OF ATRIAL FIBRILLATION: FROM INCEPTION TO CONTEMPORARY APPROACHES ; ЭВОЛЮЦИЯ ТОРАКОСКОПИЧЕСКОГО ЛЕЧЕНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: ОТ СТАНОВЛЕНИЯ ДО СОВРЕМЕННОГО ЭТАПА

Συγγραφείς: Amiran S. Revishvili, Elena A. Artyukhina, Elizaveta D. Strebkova, Egor S. Malyshenko, Madina Kadyrova, Амиран Шотаевич Ревишвили, Елена Александровна Артюхина, Елизавета Дмитриевна Стребкова, Егор Сергеевич Малышенко, Мадина Кадырова

Συνεισφορές: Авторы заявляют об отсутствии финансирования статьи.

Πηγή: Complex Issues of Cardiovascular Diseases; Том 12, № 2 (2023); 107-121 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 12, № 2 (2023); 107-121 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Левое предсердие, Atrial fibrillation, Left atrium, Фибрилляция предсердий

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1335/796; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1331; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1332; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1333; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1334; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1335; Пиданов О.Ю., Богачев-Прокофьев А.В., Елесин Д.А., Иваницкий Э. А., Бобровский О. А., Шиленко П. А., Дурыгин П. А., Зотов А. С., Вачев С. А., Вайкин В. Е., Мамчур С. Е., Сапельников О. В., Быстров Д. О. Торакоскопическая аблация для лечения пациентов с изолированной формой фибрилляции предсердий в России. Патология кровообращения и кардиохирургия. 2018;22(2):14-21. doi:10.21688/1681-3472-2018-2-14-21.; Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-221. doi:10.1177/1747493019897870.; Hindricks G., Potpara T., Dagres N., Arbelo Е., Bax J.J., Blomstrӧm-Lundqvist С., Boriani G., Castella M., Dan G., Dilaveris P.E., Fauchier L., Filippatos G., Kalman J.M., La Meir M., Lane D.A., Lebeau J., Lettino M., Lip G.Y., Pinto F.J., Neil Thomas G., Valgimigli M., Van Gelder I.C., Van Putte B.P., Watkins C.L.et al. Рекомендации ESC 2020 по диагностике и лечению пациентов с фибрилляцией предсердий, разработанные совместно с Европейской ассоциацией кардиоторакальной хирургии (EACTS). Российский кардиологический журнал. 2021;26(9):4701. doi:10.15829/1560-4071-2021-4701( doi:10.1093/eurheartj/ehaa945.); Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Métayer P., Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66. doi:10.1056/NEJM199809033391003.; Wesselink R., Neefs J., van den Berg N.W.E., Meulendijks E.R., Terpstra M.M., Kawasaki M., Nariswari F.A., Piersma F.R., van Boven W.J.P., Driessen A.H.G., de Groot J.R. Does left atrial epicardial conduction time reflect atrial fibrosis and the risk of atrial fibrillation recurrence after thoracoscopic ablation? Post hoc analysis of the AFACT trial. BMJ Open. 2022;12(3): 056829. doi:10.1136/bmjopen-2021-056829.; Артюхина Е.А., Дедух Е.В., Яшков М.В. Этапный хирургический и катетерный подход к лечению длительно-персистирующей фибрилляции предсердий. Российский кардиологический журнал. 2019;(7):96-98. doi:10.15829/1560-4071-2019-7-96-98.; Tilz R.R., Rillig A., Thum A.M., Arya A., Wohlmuth P., Metzner A., Mathew S., Yoshiga Y., Wissner E., Kuck K.H., Ouyang F. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60:1921–9. doi:10.1016/j.jacc.2012.04.060.; Teunissen C., Kassenberg W., van der Heijden J.F., Hassink R.J., van Driel V.J., Zuithoff N.P., Doevendans P.A., Loh P. Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study. Europace. 2016;18:1335–42. doi:10.1093/europace/euv439.; Cox J.L. The longstanding, persistent confusion surrounding surgery for atrial fibrillation. J Thorac Cardiovasc Surg. 2010;139:1374–86. doi:10.1016/j.jtcvs.2010.02.027.; Lapenna E., De Bonis M., Giambuzzi I., Del Forno B., Ruggeri S., Cireddu M., Gulletta S., Castiglioni A., Alfieri O., Della Bella P., Benussi S. Long-term outcomes of stand-alone Maze IV for persistent or long-standing persistent atrial fibrillation. Ann Thorac Surg. 2020;109:124–31. doi:10.1093/icvts/ivab355.; Ad N., Holmes S.D., Friehling T. Minimally invasive stand-alone Cox Maze procedure for persistent and long-standing persistent atrial fibrillation: perioperative safety and 5-year outcomes. Circ Arrhythm Electrophysiol. 2017;10:e005352. doi:10.1161/CIRCEP.117.005352.; Haldar S., Khan H.R., Boyalla V., Kralj-Hans I., Jones S., Lord J., Onyimadu O., Satishkumar A., Bahrami T., De Souza A. et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41:4471–4480. doi:10.1093/eurheartj/ehaa658.; Ohtsuka T., Nonaka T., Hisagi M., Ninomiya M. En bloc left pulmonary vein and appendage isolation in thoracoscopic surgery for atrial fibrillation. Ann Thorac Surg. 2018;106:1340–7. doi:10.1016/j.athoracsur.2018.06.065.; van Laar C., Bentala M., Weimar T., Doll N., Swaans M.J., Molhoek S.G., Hofman F.N., Kelder J., van Putte B.P. Thoracoscopic ablation for the treatment of atrial fibrillation: a systematic outcome analysis of a multicentre cohort. Europace. 2019;21:893–9. doi:10.1093/europace/euy323.; Sindby J.E., Vadmann H., Lundbye-Christensen S., Riahi S., Hjortshøj S., Boersma L.V.A., Andreasen J.J. Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial–the FAST II study. J Cardiothorac Surg. 2018;13(1): 101. doi:10.1186/s13019-018-0792-8.; Boersma L.V., Castella M., van Boven W., Berruezo A., Yilmaz A., Nadal M., Sandoval E., Calvo N., Brugada J., Kelder J., Wijffels M., Mont L. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125: 23-30. doi:10.1161/CIRCULATIONAHA.111.074047.; Saltman A.E., Rosenthal L.S., Francalancia N.A., Lahey S.J. A completely endoscopic approach to microwave ablation for atrial fibrillation. Heart Surg Forum. 2003;6:38–41.; Pruitt J.C., Lazzara R.R., Dworkin G.H. Badhwar V., Kuma C., Ebra G. Totally endoscopic ablation of lone atrial fibrillation: initial clinical experience. Ann Thorac Surg. 2006;81:1325-1330. doi:10.1016/j.athoracsur.2005.07.095.; Xu J., Luc J.G., Phan K. Atrial fibrillation: review of current treatment strategies. J Thorac Dis. 2016;8(9):886-900. doi:10.21037/jtd.2016.09.13.; Yilmaz A., Geuzebroek G.S., Van Putte B.P., Boersma L.V., Sonker U., De Bakker J.M., Van Boven W.J. Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38:356-60. doi:10.1016/j.ejcts.2010.01.058.; Pak H-N., Hwang C., Lim H.E., Kim J.S., Kim Y.H. Hybrid Epicardial and endocardial ablation of persistent or permanent atrial fibrillation: a new approach for difficult cases. J Cardiovasc Electrophysiol. 2007;18(9):917–23. doi:10.1111/j.1540-8167.2007.00882.x.; Mahapatra S., LaPar D.J., Kamath S., Payne J., Bilchick K.C., Mangrum J.M., Ailawadi G. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and longstanding persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–8. doi:10.1016/j.athoracsur.2011.02.045.; Suárez A.G. Hornero F. Berjano E.J. Mathematical modeling of epicardial RF ablation of atrial tissue with overlying epicardial fat. Open Biomed Eng J. 2010; 4: 47-55. doi:10.2174/1874120701004020047.; Thomas S.P. Guy D.J. Boyd A.C., Eipper V.E., Ross D.L., Chard R.B. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg. 2003; 75: 543-548. doi:10.1016/s0003-4975(02)04314-x.; Gaynor S.L., Diodato M.D., Prasad S.M., Ishii Y., Schuessler R.B., Bailey M.S., Damiano N.R., Bloch J.B., Moon M.R., Damiano R.J. Jr. A prospective, single-center clinical trial of a modifi ed Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128:535-542. doi:10.1016/j.jtcvs.2004.02.044.; Accord R.E., van Suylen R.J., van Brakel T.J., Maessen J.G. Post-mortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fi brillation. Ann Thorac Surg. 2005;80:881-7. doi:10.1016/j.athoracsur.2005.03.069.; Deneke T., Khargi K., Müller K.M., Lemke B., Mügge A., Laczkovics A., Becker A.E., Grewe P.H. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J. 2005;26:1797-803. doi:10.1093/eurheartj/ehi255.; Osmancik P., Budera P., Zdarska J., Herman D., Petr R., Straka Z. Electrophysiological findings after surgical thoracoscopic atrial fibrillation ablation. Heart Rhythm. 2016; 13: 1246-1252. doi:10.1016/j.hrthm.2016.02.007.; Pison L., La Meir M., van Opstal J., Blaauw Y., Maessen J., Crijns H.J. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61. doi:10.1016/j.jacc.2011.12.055.; Kurfirst V., Mokraček A., Bulava A., Čanadyova J., Haniš J., Pešl L. Two-staged hybrid treatment of persistent atrial fibrillation: shortterm single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–6. doi:10.1093/icvts/ivt538.; Wolf R.K., Schneeberger E.W., Osterday R., Miller D., Merrill W., Flege J.B. Jr., Gillinov A.M. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:797-802. doi:10.1016/j.jtcvs.2005.03.041.; Gillinov A.M., Wolf R.K. Surgical ablation of atrial fibrillation. Prog Cardiovasc Dis. 2005;48(3):169-177. doi:10.1016/j.pcad.2005.06.012.; Beyer E., Lee R., Lam B.K. Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg. 2009;137(3): 521-526. doi:10.1016/j.jtcvs.2008.11.031.; Krul S.P.J., Driessen A.H.G., Zwinderman A.H., van Boven W.J., Wilde A.A., de Bakker J.M., de Groot J.R. Navigating the mini-maze: systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol 2013;166:132–40. doi:10.1016/j.ijcard.2011.10.011.; La Meir M., Gelsomino S., Lucà F., Pison L., Colella A., Lorusso R., Crudeli E., Gensini G.F., Crijns H.G., Maessen J. Minimal invasive surgery for atrial fibrillation: an updated review. Europace. 2013;15:170–82. doi:10.1093/europace/eus216.; Ревишвили А.Ш., Кадырова М., Стребкова Е.Д., Малышенко Е.С., Новиков М.А., Ялова Е.В., Бабаджанова К.А., Бондурко К.Э., Кармазановский Г.Г. Ампутация ушка левого предсердия с использованием эндостеплера при торакоскопической аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2023;12(1):58-71. doi:10.17802/2306-1278-2023-12-1-58-71.; van Laar C., Kelder J., van Putte B.P. The totally thoracoscopic maze procedure for the treatment of atrial fibrillation. Interact Cardiovasc Thorac Surg. 2017;24(1):102-111. doi:10.1093/icvts/ivw311.; Vos L.M., Kotecha D., Geuzebroek G.S.C., Hofman F.N., van Boven W.J.P., Kelder J., de Mol B.A.J.M., van Putte B.P.Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. Europace. 2018;20(11):1790-1797. doi:10.1093/europace/eux385.; Vos L.M., Bentala M., Geuzebroek G.S., Molhoek S.G., van Putte B.P. Long-term outcome after totally thoracoscopic ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(1):40-45. doi:10.1111/jce.14267.; Choi M.S., On Y.K., Jeong D.S., Park K.M., Park S.J., Kim J.S., Carriere K.C. Usefulness of Postprocedural Electrophysiological Confirmation Upon Totally Thoracoscopic Ablation in Persistent Atrial Fibrillation. Am J Cardiol. 2020;125(7): 1054-1062. doi:10.1016/j.amjcard.2019.12.046.; Hong K.N., Russo M.J., Liberman E.A., Trzebucki A., Oz M.C., Argenziano M., Williams M.R. Effect of epicardial fat on ablation performance: a three-energy source comparison. J Card Surg. 2007; 22:521–524. doi:10.1111/j.1540-8191.2007.00454.x.; Osmancik P., Budera P., Zdarska J., Herman D., Petr R., Straka Z. Electrophysiological findings after surgical thoracoscopic atrial fibrillation ablation. Heart Rhythm. 2016;13: 1246–1252. doi:10.1016/j.hrthm.2016.02.007.; Lin J., Scherlag B.J., Lu Z., Zhang Y., Liu S., Patterson E., Jackman W.M., Lazzara R., Po S.S. Inducibility of atrial and ventricular arrhythmias along the ligament of marshall: role of autonomic factors. J Cardiovasc Electrophysiol. 2008;19:955-962. doi:10.1111/j.1540-8167.2008.01159.x.; Hocini M., Jaïs P., Sanders P., Takahashi Y., Rotter M., Rostock T., Hsu L.F., Sacher F., Reuter S., Clémenty J., Haïssaguerre M. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005;112:3688–96. doi:10.1161/CIRCULATIONAHA.105.541052.; Phan K., Xie A., Tsai Y.C., Kumar N., La Meir M., Yan T.D. Biatrial ablation vs. left atrial concomitant surgical ablation for treatment of atrial fibrillation: a meta-analysis. Europace. 2015;17(1):38–47. doi:10.1093/europace/euu220.; Edgerton J.R., Jackman W.M., Mack M.J. A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set. Ann Thorac Surg. 2009;88(5):1655-1657. doi:10.1016/j.athoracsur.2009.05.046.; Weimar T., Vosseler M., Czesla M., Boscheinen M., Hemmer W.B., Doll K.N. Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart. Ann Thorac Surg. 2012;94:1886-1892. doi:10.1016/j.athoracsur.2012.07.035.; Sirak J., Jones D., Schwartzman D. The five-box thoracoscopic maze procedure. Ann Thorac Surg. 2010;90(3):986-9. doi:10.1016/j.athoracsur.2010.05.022.; Guo Q.Z., Zhu D., Bai Z.X., Shi J., Shi Y.K., Guo Y.Q. A novel "box lesion" minimally invasive totally thoracoscopic surgical ablation for atrial fibrillation. Ann Acad Med Singap. 2015;44(1):6-12.; Doty J.R., Clayson S.E. Surgical Treatment of Isolated (Lone) Atrial Fibrillation With Gemini-S Ablation and Left Atrial Appendage Excision (GALAXY Procedure). Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2012.7(1):33–38. doi:10.1097/imi.0b013e3182560612.; Антикеев А.М., Шамуратов И.К., Дюржанов А.А., Даиров Д.С., Абильтаев А.М., Ерболатов Б.Н., Курманов А.М., Накипов Х.Х. Торакоскопическая радиочастотная аблация для лечения фибрилляции предсердий. Оперативная техника и непосредственные результаты трех клинических случаев. Анналы аритмологии. 2017; 14(3): 150-154. doi:10.15275/annaritmol.2017.3.4; Janusauskas V., Puodziukaite L., Maneikiene V.V., Zuoziene G., Radauskaite G., Burneikaite G., Samalavicius R.S., Aidietiene S., Rucinskas K., Aidietis A. Long-term results of minimally invasive stand-alone bi-atrial surgical ablation with a bipolar ablation device for persistent and longstanding persistent AF: a single center case series of 91 patients. J Cardiothorac Surg. 2016; 11(1): 23-31. doi:10.1186/s13019-016-0416-0.; Harlaar N., Oudeman M.A., Trines S.A., de Ruiter G.S., Mertens B.J., Khan M., Klautz R.J.M., Zeppenfeld K., Tjon A., Braun J., van Brakel T.J. Long-term follow-up of thoracoscopic ablation in long-standing persistent atrial fibrillation. Interact Cardiovasc Thorac Surg. 2022;34(6):990-998. doi:10.1093/icvts/ivab355.; Harlaar N., Verberkmoes N.J., van der Voort P.H., Trines S.A., Verstraeten S.E., Mertens B.J.A., Klautz R.J.M., Braun J., van Brakel T.J. Clamping versus nonclamping thoracoscopic box ablation in long-standing persistent atrial fibrillation. J Thorac Cardiovasc Surg. 2020;160:399–405. doi:10.1016/j.jtcvs.2019.07.104.; Fleerakkers J., Hofman F.N., van Putte B.P. Totally thoracoscopic ablation: a unilateral right-sided approach. Eur J Cardiothorac Surg. 2020 Nov 1;58(5):1088-1090. doi:10.1093/ejcts/ezaa160.; Bisleri G., Manzato A., Argenziano M., Vigilance D.W., Muneretto C. Thoracoscopic epicardial pulmonary vein ablation for lone paroxysmal atrial fibrillation. Europace. 2005 Mar;7(2):145-8. doi:10.1016/j.eupc.2004.12.005.; Haywood G.A., Varini R., Osmancik P., Cireddu M., Caldwell J., Chaudhry M.A., Loubani M., Della Bella P., Lapenna E., Budera P., Dalrymple-Hay M. European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation. Int J Cardiol Heart Vasc. 2020;26:100459. doi:10.1016/j.ijcha.2019.100459.; Rosati F., Muneretto C., Merati E., Polvani G., Moltrasio M., Tondo C., Curnis A., Cerini M., Metras A., Bisleri G. Epicardial, Biatrial Ablation With Integrated Uni-bipolar Radiofrequency Technology in Stand-alone Persistent Atrial Fibrillation. Innovations (Phila). 2018;13(2):114-119. doi:10.1097/IMI.0000000000000482.; Muneretto C., Bisleri G., Bontempi L., Curnis A. Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg. 2012;144: 1460 – 5. doi:10.1016/j.jtcvs.2012.08.069.; Артюхина Е.А., Ревишвили А.Ш., Малашенко Е.С., Мунеретто С. Первый опыт устранения длительно-персистирующей формы фибрилляции предсердий с использованием торакоскопической радиочастотной аблации. Инновационная медицина Кубани. 2017;5(1):23-27.; Muneretto C., Bisleri G., Rosati F., Krakor R., Giroletti L., Di Bacco L., Repossini A., Moltrasio M., Curnis A., Tondo C., Polvani G. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial. Eur J Cardiothorac Surg. 2017;52(4):740-745. doi:10.1093/ejcts/ezx162.; Maesen B., La Meir M. Unilateral Left-sided Thoracoscopic Ablation of Atrial Fibrillation. Ann Thorac Surg. 2020 Jul;110(1):e63-e66. doi:10.1016/j.athoracsur.2020.01.057.; Ellis C.R., Badhwar N., Tschopp D., Danter M., Jackson G.G., Kerendi F., Walters T., Fang Q., Deuse T., Beygui R., Lee R.J. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results. JACC Clin Electrophysiol. 2020;6(13):1603-1615. doi:10.1016/j.jacep.2020.06.011.; Wats K., Kiser A., Makati K., Sood N., DeLurgio D., Greenberg Y., Yang F. The Convergent AF Ablation Procedure: Evolution of a Multidisciplinary Approach to AF Management. Arrhythmia & Electrophysiology Review. 2020;9(2):88–96. doi:10.15420/aer.2019.20.; Kiser A.C., Landers M., Horton R., Hume A., Natale A., Gersak B. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13:317–21. doi:10.1532/HSF98.20091112.; Zembala M., Filipiak K., Kowalski O., Boidol J., Sokal A., Lenarczyk R., Niklewski T., Garbacz M., Nadziakiewicz P., Kalarus Z., Zembala M. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70:819–28.; Gehi A.K., Mounsey J.P., Pursell I., Landers M., Boyce K., Chung E.H., Schwartz J., Walker T.J., Guise K., Kiser A.C. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10:22–8.; Gersak B., Jan M. Long-term success for the convergent atrial fibrillation procedure: 4-year outcomes. Ann Thorac Surg. 2016;102:1550–7. doi:10.1016/j.athoracsur.2016.04.018.; Хоменко Е.А., Мамчур С.Е., Козырин К.А., Тарасов Р.С., Баковский К.В. Ближайшие и среднесрочные результаты торакоскопической радиочастотной аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2019; 8 (4S): 82-88. doi:10.17802/2306-1278-2019-8-4S-82-88.; van der Heijden C.A.J., Weberndörfer V., Luermans J.G.L.M., Chaldoupi S.M., van Kuijk S.M.J., Vroomen M., Bidar E., Maessen J.G., Pison L., La Meir M., Maesen B. Hybrid ablation of atrial fibrillation: A unilateral left-sided thoracoscopic approach. J Card Surg. 2022;37(12):4630-4638. doi:10.1111/jocs.17144.; Maesen B., van der Heijden C.A.J., Bidar E., Vos R., Athanasiou T., Maessen J.G. Patient-reported quality of life after stand-alone and concomitant arrhythmia surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2022;34(3):339-348. doi:10.1093/icvts/ivab282.

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1335
https://doi.org/10.17802/2306-1278-2023-12-2-107-121

RISK FACTORS FOR ATRIAL TACHYARRHYTHMIA RECURRENCE IN PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION AFTER «BOX LESION SET» THORACOSCOPIC ABLATION ; ФАКТОРЫ РИСКА ВОЗВРАТА ПРЕДСЕРДНЫХ ТАХИАРИТМИЙ У ПАЦИЕНТОВ С НЕПАРОКСИЗМАЛЬНЫМИ ФОРМАМИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПОСЛЕ ТОРАКОСКОПИЧЕСКОЙ АБЛАЦИИ BOX LESION SET

Συγγραφείς: Madina Kadyrova, Elizaveta D. Strebkova, Evgeniya V. Yalova, Grigory G. Karmazanovsky, Amiran S. Revishvili, Мадина Кадырова, Елизавета Дмитриевна Стребкова, Евгения Владиславовна Ялова, Григорий Григорьевич Кармазаноский, Амиран Шотаевич Ревишвили

Συνεισφορές: Авторы заявляют об отсутствии финансирования исследования.

Πηγή: Complex Issues of Cardiovascular Diseases; Том 12, № 4 (2023); 96-107 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 12, № 4 (2023); 96-107 ; 2587-9537 ; 2306-1278

Θεματικοί όροι: Факторы риска, Thoracoscopic ablaton, Risk factors, Торакоскопическая аблация

Περιγραφή αρχείου: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1360/839; Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5. doi:10.1001/jama.285.18.2370. 2370; Berger W.R., Meulendijks E.R., Limpens J., van den Berg N.W.E., Neefs J., Driessen A.H.G., Krul S.P.J., van Boven W.J.P., de Groot J.R. Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies. Int J Cardiol. 2019;278:137-143. doi:10.1016/j.ijcard.2018.11.127.; Ревишвили А.Ш., Артюхина Е.А., Стребкова Е.Д., Малышенко Е.С., Кадырова М. Эволюция торакоскопического лечения фибрилляции предсердий: от становления до современного этапа. Комплексные проблемы сердечно-сосудистых заболеваний. 2023;12(2):107-121. doi:10.17802/2306-1278-2023-12-2-107-121; Driessen A.H.G., Berger W.R., Krul S.P.J., van den Berg N.W.E., Neefs J., Piersma F.R., Chan Pin Yin D.R.P.P., de Jong J.S.S.G., van Boven W.P., de Groot J.R. Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study. J Am Coll Cardiol. 2016;68(11):1155-1165. doi:10.1016/j.jacc.2016.06.036.; Yu C., Li H., Zhang H., Zheng Z. Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation. Interact Cardiovasc Thorac Surg. 2021;33(3):354-361. doi:10.1093/icvts/ivab148.; Guo Q.Z., Zhu D., Bai Z.X., Shi J., Shi Y.K., Guo Y.Q. A novel "box lesion" minimally invasive totally thoracoscopic surgical ablation for atrial fibrillation. Ann Acad Med Singap. 2015;44(1):6-12.; Haldar S., Khan H.R., Boyalla V., Kralj-Hans I., Jones S., Lord J., Onyimadu O., Satishkumar A., Bahrami T., De Souza A., Clague J.R., Francis D.P., Hussain W., Jarman J.W., Jones D.G., Chen Z., Mediratta N., Hyde J., Lewis M., Mohiaddin R., Salukhe T.V., Murphy C., Kelly J., Khattar R.S., Toff W.D., Markides V., McCready J., Gupta D., Wong T. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41(47):4471-4480. doi:10.1093/eurheartj/ehaa658.; Khan H.R., Kralj-Hans I., Haldar S., Bahrami T., Clague J., De Souza A., Francis D., Hussain W., Jarman J., Jones D.G., Mediratta N, Mohiaddin R, Salukhe T, Jones S, Lord J, Murphy C, Kelly J, Markides V, Gupta D, Wong T. Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial. Trials. 2018;19(1):117. doi:10.1186/s13063-018-2487-9.; Han F.T. , Kasirajan V., Kowalski M., Kiser R., Wolfe L., Kalahasty G., Shepard R.K., Wood M.A., Ellenbogen K.A. Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation: single-center experience with 12-month follow-up. Circ Arrhythm Electrophysiol. 2009;2(4):370-7. doi:10.1161/CIRCEP.109.854828.; Boersma L.V., Castella M., van Boven W., Berruezo A., Yilmaz A., Nadal M., Sandoval E., Calvo N., Brugada J., Kelder J., Wijffels M., Mont L. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23-30. doi:10.1161/CIRCULATIONAHA.111.074047.; Sindby J.E. Vadmann H., Lundbye-Christensen S., Riahi S., Hjortshøj S., Boersma L.V.A., Andreasen J.J. Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study. J Cardiothorac Surg. 2018;13(1):101. doi:10.1186/s13019-018-0792-8.; DeWith R.R., Marcos E.G., Van Gelder I.C., Rienstra M. Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation. Europace. 2018; 20:1750-7. doi:10.1093/europace/euy028; Loghin C., Karimzadehnajar K., Ekeruo I.A., Mukerji S.S., Memon N.B., Kantharia B.K. Outcome of pulmonary vein isolation ablation for paroxysmal atrial fibrillation: predictive role of left atrial mechanical dyssynchrony by speckle tracking echocardiography. J Interv Card Electrophysiol. 2014;39(1):7-15. doi:10.1007/s10840-013-9841-3; Апарина О.П., Стукалова О.В., Пархоменко Д.В., Миронова Н.А., Буторова Е.А., Болотова, М.Н., Макеев М.И., Терновой С.К., Голицын С.П. Характеристика структуры миокарда левого предсердия у больных мерцательной аритмией и здоровых лиц по данным магнитнорезонансной томографии с отсроченным контрастированием. Вестник аритмологии. 2014;(77):5-12.; Стребкова Е.Д., Ревишвили А.Ш., Малышенко Е.С., Артюхина Е.А., Попов В.А., Новиков, М.А., Ялова Е.В., Бондурко К.Э., Кармазановский Г.Г., Кадырова М. Отдаленные результаты торакоскопического лечения фибрилляции предсердий. Вестник аритмологии. 2023;30(2):59-69. doi:10.35336/VA-2023-2-08; Ревишвили А.Ш., Кадырова М., Попов В.А., Малышенко Е.С., Кармазановский Г.Г., Стребкова Е.Д., Широков В.С., Новиков М.А., Ялова Е.В., Таймасова И.А. Влияние индексируемого объема левого предсердия на эффективность торакоскопического лечения фибрилляции предсердий. Медицинская визуализация. 2022;26(3):22-33. doi:10.24835/1607-0763-1162; Ревишвили АШ, Таймасова ИА, Артюхина ЕА, Малышенко Е.С., Новиков М.В., Стребкова Е.Д. Среднесрочные результаты торакоскопического и гибридного лечения фибрилляции предсердий. Вестник аритмологии. 2021;28(3): 5-12. doi:10.35336/VA-2021-3-5-12; Baalman S.W.E., Lopes R.R., Ramos L.A., Neefs J., Driessen A.H.G., van Boven W.P., de Mol B.A.J.M., Marquering H.A., de Groot J.R. Prediction of Atrial Fibrillation Recurrence after Thoracoscopic Surgical Ablation Using Machine Learning Techniques. Diagnostics (Basel). 2021;11(10):1787. doi:10.3390/diagnostics11101787.; Badano L.P., Kolias T.J., Muraru D., Abraham T.P., Aurigemma G., Edvardsen T., D'Hooge J., Donal E., Fraser A.G., Marwick T., Mertens L., Popescu B.A., Sengupta P.P., Lancellotti P., Thomas J.D., Voigt J.U.; Industry representatives; Reviewers: This document was reviewed by members of the 2016–2018 EACVI Scientific Documents Committee. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591-600. doi:10.1093/ehjci/jey042.; Кадырова М., Ялова Е.В., Шебзухова Ф.С., Боташева А.А., Стребкова Е.Д., Кармазановский Г.Г., Ревишвили А.Ш. Современные методы эхокардиографической оценки функционального состояния левого предсердия при фибрилляции предсердий. Медицинская визуализация. 2023;27(3):24-40. doi:10.24835/1607-0763-1360; Ревишвили А.Ш., Сергуладзе С.Ю., Кваша Б.И., Такаландзе Р.Г., Гоголадзе Д.К., Маслова И.И., Сопов О.В., Васковский В.А. Ближайшие и отдаленные результаты хирургического лечения «изолированных» форм фибрилляции предсердий с помощью радиочастотной модификации операции «Лабиринт-V». Вестник аритмологии. 2016;(83):23-31; Васковский В.А., Ревишвили А.Ш., Сергуладзе С.Ю., Кваша Б.И., Такаландзе Р.Г., Маслова И.И. Клинические предикторы отдаленной эффективности радиочастотной модификации операции "Лабиринт" на работающем сердце у пациентов с пароксизмальной и персистирующей формой фибрилляции предсердий. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2015;16(S6): 81.; van Laar C., Kelder J., van Putte B.P. The totally thoracoscopic maze procedure for the treatment of atrial fibrillation. Interact Cardiovasc Thorac Surg. 2017;24(1):102-111. doi:10.1093/icvts/ivw311; Gillinov A.M., Sirak J., Blackstone E.H., McCarthy P.M., Rajeswaran J., Pettersson G., Sabik F.J. 3rd, Svensson L.G., Navia J.L., Cosgrove D.M., Marrouche N., Natale A. The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(6):1653-60. doi:10.1016/j.jtcvs.2005.07.028.; Damiano R.J.Jr., Schwartz F.H., Bailey M.S., Maniar H.S., Munfakh N.A., Moon M.R., Schuessler R.B. The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141(1):113-21. doi:10.1016/j.jtcvs.2010.08.067.; Dretzke J., Chuchu N., Agarwal R., Herd C., Chua W., Fabritz L., Bayliss S., Kotecha D., Deeks J.J., Kirchhof P., Takwoingi Y. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace. 2020;22(5):748-760. doi:10.1093/europace/euaa041.; Гурина В.И., Кондратьев Е.В., Кармазановский Г.Г., Хацаюк Е.А. МСКТ-волюметрия левого предсердия у пациентов кардиологического профиля. Медицинская визуализация. 2017;(6):13-18. doi:10.24835/1607-0763-2017-6-13-18; Neefs J., Wesselink R., van den Berg N.W.E., de Jong J.S.S.G., Piersma F.R., van Boven W.P., Driessen A.H.G., de Groot J.R. Thoracoscopic surgical atrial fibrillation ablation in patients with an extremely enlarged left atrium. J Interv Card Electrophysiol. 2022;64(2):469-478. doi:10.1007/s10840-021-01056-1; Park C.S., Choi E.K., Lee S.R., Ahn H.J., Kwon S., Kim S., Sohn S.H., Choi J.W., Hwang H.Y., Oh S. Catheter ablation and thoracoscopic ablation in long persistent atrial fibrillation with large left atrium. Front Cardiovasc Med. 2022;9:881831. doi:10.3389/fcvm.2022.881831.; Shin S.H., Park M.Y., Oh W.J., Hong S.J., Pak H.N., Song W.H., Lim D.S., Kim Y.H., Shim W.J. Left atrial volume is a predictor of atrial fibrillation recurrence after catheter ablation. J Am Soc Echocardiogr. 2008;21(6):697-702. doi:10.1016/j.echo.2007.10.022; Gwag H.B., Jeong D.S., Hwang J.K., Park S.J., Park K.M., Kim J.S., On Y.K. Additional cavotricuspid isthmus ablation may reduce recurrent atrial tachyarrhythmia after total thoracoscopic ablation for persistent atrial fibrillation. Interact Cardiovasc Thorac Surg. 2019;28(2):177-182. doi:10.1093/icvts/ivy236; Lim S.K., Chung S., Park I., Chi S.A., Kim K., Park K.M., Park S.J., Kim J.Y., Kim J.S., On Y.K., Jeong D.S. Totally Thoracoscopic Ablation in Patients With Recurrent Atrial Fibrillation After Catheter Ablation. J Korean Med Sci. 2023;38(39):e320. doi:10.3346/jkms.2023.38.e320; Baalman S.W.E., van den Berg N.W.E., Neefs J., Berger W.R., Meulendijks E.R., de Bruin-Bon R.H.A.C.M., Bouma B.J., van Boven W.J.P., Driessen A.H.G., de Groot J.R. Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT study. Int J Cardiovasc Imaging. 2022;38(12):2615-2624. doi:10.1007/s10554-022-02645-5; Мусин Т.И., Багманова З.А., Гареев Д.А., Руденко В.Г., Загидуллин Н.Ш.Прогнозирование контроля синусового ритма после радиочастотной аблации у больных с фибрилляцией предсердий с помощью технологии спекл-трекинг и динамика структурно-функциональных показателей левого предсердия. Российский кардиологический журнал. 2021; 26(2S): 42-56. doi:10.15829/1560-4071-2021-425

Διαθεσιμότητα: https://www.nii-kpssz.com/jour/article/view/1360
https://doi.org/10.17802/2306-1278-2023-12-4-96-107